US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NVIDIA Portfolio

1,794.63

-154.1749-7.91%

Number of Gainers:- -

Number of Losers:8

Number of Flat:- -

PE:- -

High:1,938.06

Open:1,938.06

Low:1,749.72

Close:1,948.80

Loading ...

Jim Cramer on WeRide (WRD): “Oh Geez, You Cut Me to the Quick – I Only Like Alibaba!”

Is Bausch Health Companies Inc. (BHC) the Best Low Price Pharma Stock to Invest In Right Now?

Is Grifols, S.A. (GRFS) the Best Low Price Pharma Stock to Invest In Right Now?

Is Haleon plc (HLN) the Best Low Price Pharma Stock to Invest In Right Now?

Is Walgreens Boots Alliance, Inc. (WBA) the Best Low Price Pharma Stock to Invest In Right Now?

Is Viatris Inc. (VTRS) the Best Low Price Pharma Stock to Invest In Right Now?

Is Dr. Reddy’s Laboratories Limited (RDY) the Best Low Price Pharma Stock to Invest In Right Now?

Is Takeda Pharmaceutical Company Limited (TAK) the Best Low Price Pharma Stock to Invest In Right Now?

Is Teva Pharmaceutical Industries Limited (TEVA) the Best Low Price Pharma Stock to Invest In Right Now?

Why SoundHound AI, Inc. (SOUN) Soared on Wednesday

CARsgen Therapeutics to Trim Stake in Biotech Arm After Third-Party Investment

MT Newswires Live

Could Buying SoundHound AI After the Stock's 55% Decline Make You a Millionaire?

Wipro Commits $200 Million to Venture Arm for Startup Investments

MT Newswires Live

Shakti Pumps (India) Invests Additional INR60 Million in Wholly-Owned Arm; Shares Down 5%

MT Newswires Live

Jupiter Wagons Arm Bags Order Worth INR2.55 Billion

MT Newswires Live

Why SOUN and GM Are Advancing Today

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/stock/BK4609/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4609"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4609\",,,,,undefined,":{"symbol":"BK4609","market":"US","secType":"PLATE","nameCN":"NVIDIA Portfolio","latestPrice":1794.63,"timestamp":1741636799999,"preClose":1948.8049,"halted":0,"volume":116279853,"delay":0,"changeRate":-0.079113,"change":-154.174927,"pbRate":13.11498,"amount":1956052152.797049,"amplitude":0.096641,"prevYearClose":2189.1055,"fiveDayClose":1924.5844,"twentyDayClose":2593.086,"turnoverRate":0.091387,"marketCap":141166595584,"floatMarketCap":26844528384,"peRate":-108.333967},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4609\",,,,,undefined,":{"symbol":"BK4609","high":1938.0576,"amplitude":0.096641,"preClose":1948.8049,"low":1749.7235,"pbRate":"13.11498","latestPrice":1794.63,"volume":116279853,"delay":0,"open":1938.0576,"prevYearClose":2189.1055,"prevWeekClose":1948.8049,"prevMonthClose":2124.3938,"prevQuarterClose":2189.1055,"fiveDayClose":1924.5844,"twentyDayClose":2593.086,"sixtyDayClose":2328.5637,"secType":"PLATE","market":"US","turnoverRate":0.091387,"peRate":-108.333967,"marketCap":141166595584,"floatMarketCap":26844528384,"timestamp":1741636799999,"nameCN":"NVIDIA Portfolio"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4609\",,,,undefined,":{"bkCode":"BK4609","up":0,"down":8,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4609\",pageSize:16,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514331644","title":"Jim Cramer on WeRide (WRD): “Oh Geez, You Cut Me to the Quick – I Only Like Alibaba!”","url":"https://stock-news.laohu8.com/highlight/detail?id=2514331644","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514331644?lang=en_us&edition=fundamental","pubTime":"2025-02-28 02:59","pubTimestamp":1740682759,"startTime":"0","endTime":"0","summary":"We recently published a list of 7 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where WeRide  stands against other stocks on Jim Cramer’s radar. Jim Cramer, host of Mad Money, recently shared his thoughts on the prevailing negative sentiment surrounding data centers and discussed the broader economic implications of Trump’s tariffs, especially their effect on consumer confidence.“The rebellion against the data center continues. That’s the dominant theme of this market. Don’t anyone tell you otherwise… How do I know this? Aren’t there more cross-currents than that? Oh, of course, there are. I mean there’s the endless tariff Trump beat, one that’s driven stocks lower en masse incredibly.”READ ALSO:Jim Cramer Commented on 12 Stocks Linked to Data CentersandJim Cramer on 10 Stocks With The Biggest Declines Last Week. Why are we interested in the stocks that hedge funds pile into?The reason is simple: our research has shown that we can outperform the mar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jim-cramer-weride-wrd-oh-185919845.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2111349929.HKD","QLD","LU0158827948.USD","NVIW.SI","LU2089283258.USD","LU1989772923.USD","LU0314104364.USD","TSYW.SI","LU0320765646.SGD","LU2089284900.SGD","LU0912757837.SGD","LU1363072403.SGD","LU1548497426.USD","LU2028103732.USD","LU0158827781.USD","BK4609","LU1989772840.SGD","BK4127","LU1668664300.SGD","QID","LU1162221912.USD","LU2271345857.HKD","LU0225283273.USD","TQQQ","BK4504","LU0795875086.SGD","USAW.SI",".IXIC","IE00BZ1G4Q59.USD","BK4516","LU2023251221.USD","BK4581","PSQ","USJW.SI","BK4588","WRD","LU0267386448.USD","LU1720051017.SGD","LU1074936037.SGD","LU1732799900.SGD","IE00BKVL7J92.USD","LU1720051108.HKD","SQQQ","NQmain","MNQmain","LU2347655156.SGD","LU0106261372.USD","LU0006306889.USD"],"gpt_icon":1},{"id":"2514130386","title":"Is Bausch Health Companies Inc. (BHC) the Best Low Price Pharma Stock to Invest In Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514130386","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514130386?lang=en_us&edition=fundamental","pubTime":"2025-02-27 22:18","pubTimestamp":1740665925,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now.In this article, we are going to take a look at where Bausch Health Companies Inc.  stands against the other pharma stocks.The Rising Demand for Weight-Loss Medications and GLP-1 Developments. Competition with the leading companies in the anti-obesity business, which is expected to grow to $130 billion by 2030, is no longer the main emphasis. The possibility for additional participants to enter the field is growing along with the possible applications of GLP-1s. For example, the Swiss business Roche entered the weight-loss drug sweepstakes last year when it paid up to $3.1 billion to acquire California-based Carmot Therapeutics. The corporation wants to \"fast-track\" its anti-obesity medicines to regain faith in its pipeline and take a s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bausch-health-companies-inc-bhc-141845594.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4543","BK4141","LU0348723411.USD","BHC","BK4007","BK4588","BK4609","CAGR","IE00BMPRXQ63.HKD","IE00BMPRXN33.USD","IE00BMPRXR70.SGD","BK4585","BK4159"],"gpt_icon":1},{"id":"2514887013","title":"Is Grifols, S.A. (GRFS) the Best Low Price Pharma Stock to Invest In Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514887013","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514887013?lang=en_us&edition=fundamental","pubTime":"2025-02-27 22:16","pubTimestamp":1740665790,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now.In this article, we are going to take a look at where Grifols, S.A.  stands against the other pharma stocks.The Rising Demand for Weight-Loss Medications and GLP-1 Developments. Competition with the leading companies in the anti-obesity business, which is expected to grow to $130 billion by 2030, is no longer the main emphasis. The possibility for additional participants to enter the field is growing along with the possible applications of GLP-1s. For example, the Swiss business Roche entered the weight-loss drug sweepstakes last year when it paid up to $3.1 billion to acquire California-based Carmot Therapeutics. The corporation wants to \"fast-track\" its anti-obesity medicines to regain faith in its pipeline and take a share of the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/grifols-grfs-best-low-price-141630338.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0348723411.USD","QID","IE00BMPRXQ63.HKD","BK4139","BK4585","BK4141","IG","BK4609","QLD","BK4543","IE00BMPRXN33.USD","MNQmain","TQQQ","TSYW.SI","USJW.SI","CAGR","PSQ","USAW.SI","GRFS","NQmain","SQQQ",".IXIC","BK4159","BK4588","NVIW.SI","IE00BMPRXR70.SGD"],"gpt_icon":1},{"id":"2514385594","title":"Is Haleon plc (HLN) the Best Low Price Pharma Stock to Invest In Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385594","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514385594?lang=en_us&edition=fundamental","pubTime":"2025-02-27 22:10","pubTimestamp":1740665430,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now.In this article, we are going to take a look at where Haleon plc  stands against the other pharma stocks.The Rising Demand for Weight-Loss Medications and GLP-1 Developments. Competition with the leading companies in the anti-obesity business, which is expected to grow to $130 billion by 2030, is no longer the main emphasis. The possibility for additional participants to enter the field is growing along with the possible applications of GLP-1s. For example, the Swiss business Roche entered the weight-loss drug sweepstakes last year when it paid up to $3.1 billion to acquire California-based Carmot Therapeutics. The corporation wants to \"fast-track\" its anti-obesity medicines to regain faith in its pipeline and take a share of the weight","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/haleon-plc-hln-best-low-141030151.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4183","BK4007","BK4585","IE00BMPRXN33.USD","HLN","BK4609","BK4543","CAGR","IE00BMPRXQ63.HKD","BK4159","BK4588","IE00BMPRXR70.SGD","LU0348723411.USD","BK4141"],"gpt_icon":1},{"id":"2514394383","title":"Is Walgreens Boots Alliance, Inc. (WBA) the Best Low Price Pharma Stock to Invest In Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514394383","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514394383?lang=en_us&edition=fundamental","pubTime":"2025-02-27 22:08","pubTimestamp":1740665318,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now.In this article, we are going to take a look at where Walgreens Boots Alliance, Inc.  stands against the other pharma stocks.The Rising Demand for Weight-Loss Medications and GLP-1 Developments. Competition with the leading companies in the anti-obesity business, which is expected to grow to $130 billion by 2030, is no longer the main emphasis. The possibility for additional participants to enter the field is growing along with the possible applications of GLP-1s. For example, the Swiss business Roche entered the weight-loss drug sweepstakes last year when it paid up to $3.1 billion to acquire California-based Carmot Therapeutics. The corporation wants to \"fast-track\" its anti-obesity medicines to regain faith in its pipeline and take","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/walgreens-boots-alliance-inc-wba-140838400.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["USJW.SI","TQQQ","NVIW.SI","USAW.SI","MNQmain","QLD","LU0321505868.SGD","IE00BMPRXN33.USD","BK4609","NQmain","BK4585","PSQ","TSYW.SI","LU0321505439.SGD","CAGR","IE00BMPRXQ63.HKD","IE00BMPRXR70.SGD","BK4128","BK4141","SQQQ","BK4543","LU0348723411.USD","BK4159","BK4588","QID","WBA",".IXIC"],"gpt_icon":1},{"id":"2514268385","title":"Is Viatris Inc. (VTRS) the Best Low Price Pharma Stock to Invest In Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514268385","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514268385?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:52","pubTimestamp":1740664373,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now.In this article, we are going to take a look at where Viatris Inc.  stands against the other pharma stocks.The Rising Demand for Weight-Loss Medications and GLP-1 Developments. Competition with the leading companies in the anti-obesity business, which is expected to grow to $130 billion by 2030, is no longer the main emphasis. The possibility for additional participants to enter the field is growing along with the possible applications of GLP-1s. For example, the Swiss business Roche entered the weight-loss drug sweepstakes last year when it paid up to $3.1 billion to acquire California-based Carmot Therapeutics. The corporation wants to \"fast-track\" its anti-obesity medicines to regain faith in its pipeline and take a share of the w","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/viatris-inc-vtrs-best-low-135253385.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","PSQ","CAGR","BK4583","BK4585","TSYW.SI","USJW.SI","USAW.SI","BK4141","IE00BMPRXQ63.HKD","QID","LU0348723411.USD","BK4609","QLD","TQQQ",".IXIC","LU1839511570.USD","NVIW.SI","BK4159","VTRS","SQQQ","MNQmain","IE00BMPRXN33.USD","IE00BMPRXR70.SGD","NQmain","BK4543","LU2087621335.USD","BK4588"],"gpt_icon":1},{"id":"2514938590","title":"Is Dr. Reddy’s Laboratories Limited (RDY) the Best Low Price Pharma Stock to Invest In Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514938590","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514938590?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:48","pubTimestamp":1740664098,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now.In this article, we are going to take a look at where Dr. Reddy's Laboratories Limited  stands against the other pharma stocks.The Rising Demand for Weight-Loss Medications and GLP-1 Developments. Competition with the leading companies in the anti-obesity business, which is expected to grow to $130 billion by 2030, is no longer the main emphasis. The possibility for additional participants to enter the field is growing along with the possible applications of GLP-1s. For example, the Swiss business Roche entered the weight-loss drug sweepstakes last year when it paid up to $3.1 billion to acquire California-based Carmot Therapeutics. The corporation wants to \"fast-track\" its anti-obesity medicines to regain faith in its pipeline and take","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dr-reddy-laboratories-limited-rdy-134818206.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4532","BK4159","BK4543","BK4007","BK4557","BK4585","IE00BMPRXN33.USD","LU0348723411.USD","ARM","LU0348744763.USD","IE00BMPRXR70.SGD","RDY","IE00BMPRXQ63.HKD","BK4213","BK4523","NRT","CAGR","BK4609","BK4596","BK4141","BK4588"],"gpt_icon":0},{"id":"2514072568","title":"Is Takeda Pharmaceutical Company Limited (TAK) the Best Low Price Pharma Stock to Invest In Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514072568","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514072568?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:43","pubTimestamp":1740663800,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now.In this article, we are going to take a look at where Takeda Pharmaceutical Company Limited  stands against the other pharma stocks.The Rising Demand for Weight-Loss Medications and GLP-1 Developments. Competition with the leading companies in the anti-obesity business, which is expected to grow to $130 billion by 2030, is no longer the main emphasis. The possibility for additional participants to enter the field is growing along with the possible applications of GLP-1s. For example, the Swiss business Roche entered the weight-loss drug sweepstakes last year when it paid up to $3.1 billion to acquire California-based Carmot Therapeutics. The corporation wants to \"fast-track\" its anti-obesity medicines to regain faith in its pipeline and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/takeda-pharmaceutical-company-limited-tak-134320152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4585","BK4609","CAGR","IE00BMPRXN33.USD","IE00BMPRXQ63.HKD","BK4159","BK4141","BK4007","TAK","IE00BMPRXR70.SGD","LU0348723411.USD","BK4543"],"gpt_icon":1},{"id":"2514831388","title":"Is Teva Pharmaceutical Industries Limited (TEVA) the Best Low Price Pharma Stock to Invest In Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514831388","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514831388?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:34","pubTimestamp":1740663253,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now.In this article, we are going to take a look at where Teva Pharmaceutical Industries Limited  stands against the other pharma stocks.The Rising Demand for Weight-Loss Medications and GLP-1 Developments. Competition with the leading companies in the anti-obesity business, which is expected to grow to $130 billion by 2030, is no longer the main emphasis. The possibility for additional participants to enter the field is growing along with the possible applications of GLP-1s. For example, the Swiss business Roche entered the weight-loss drug sweepstakes last year when it paid up to $3.1 billion to acquire California-based Carmot Therapeutics. The corporation wants to \"fast-track\" its anti-obesity medicines to regain faith in its pipeline a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/teva-pharmaceutical-industries-limited-teva-133413831.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4543","BK4609","IE00BMPRXN33.USD","BK4588","BK4566","BK4559","IE00BMPRXQ63.HKD","IE00BMPRXR70.SGD","BK4141","BK4584","BK4585","BK4596","BK4159","CAGR","LU0348723411.USD","BK4007","TEVA","BK4557"],"gpt_icon":1},{"id":"2514980469","title":"Why SoundHound AI, Inc. (SOUN) Soared on Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2514980469","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514980469?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:58","pubTimestamp":1740661090,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 Stocks Outperform Wall Street Indices on Wednesday.In this article, we are going to take a look at where SoundHound AI, Inc. stands against the other stocks.The stock market ended on a mixed note on Wednesday, with the Dow Jones the sole loser during the session, as investor caution persisted amid confusing tariff policies from President Donald Trump.SoundHound AI, Inc. firmed up on Wednesday, finishing the day up by 7.53 percent to close at $9.57 apiece as investors bought up shares ahead of the release of its earnings performance on Thursday, February 27.In addition, funds poured into quantum computing stocks, including SoundHound AI, Inc., following Nvidia Corp.’s announcement of its fourth-quarter earnings release after market close on Wednesday.It can be recalled that SoundHound AI, Inc. was one of the stocks sold off by NVDA over the past few months, but the outlook remained bullish for the company following earlier statements from NVDA CEO J","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-soundhound-ai-inc-soun-125810461.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TQQQ","NVDA","SOUN","BK4023","NQmain","USAW.SI","MNQmain","QLD","TSYW.SI","QID","BK4609","PSQ","USJW.SI","SOUNW","BK4547","BK4587",".IXIC","BK4608","SQQQ","NVIW.SI"],"gpt_icon":1},{"id":"2514987977","title":"CARsgen Therapeutics to Trim Stake in Biotech Arm After Third-Party Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2514987977","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514987977?lang=en_us&edition=fundamental","pubTime":"2025-02-27 18:13","pubTimestamp":1740651198,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics'  equity interest in subsidiary, UCARsgen Biotech, will decline to 92% from 100% after an investment fund subscribes for its additional registered capital for 80 million yuan, a Wednesday filing with the Hong Kong bourse said.The investment fund is being managed by Zhuhai Hengqin SB Xinchuang Equity Investment Management, according to the biopharmaceutical company.Under the contract, UCARsgen Biotech has secured the exclusive rights for the R&D, manufacture, and commercialization of two allogeneic CAR-T products in mainland China.UCARsgen Biotech is a new drug discovery biotechnology company focused on allogeneic CAR-T cell therapies for the treatment of hematologic malignancies.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0348723411.USD","BK1574","BK4588","LENZ","BK4585","IE00BMPRXR70.SGD","BK1585","BK4141","BK4139","BK4543","BK4609","IE00BMPRXQ63.HKD","BK1161","IE00BMPRXN33.USD","BK1587","02171"],"gpt_icon":1},{"id":"2514873812","title":"Could Buying SoundHound AI After the Stock's 55% Decline Make You a Millionaire?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514873812","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514873812?lang=en_us&edition=fundamental","pubTime":"2025-02-27 16:15","pubTimestamp":1740644100,"startTime":"0","endTime":"0","summary":"Investors are trying to gauge whether the stock's sudden decline is a buying opportunity or a sign of what's to come.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/02/27/could-buying-soundhound-ai-after-the-stocks-55-dec/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4608","BK4587","BK4023","BK4547","BK4609","SOUN"],"gpt_icon":1},{"id":"2514829496","title":"Wipro Commits $200 Million to Venture Arm for Startup Investments","url":"https://stock-news.laohu8.com/highlight/detail?id=2514829496","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514829496?lang=en_us&edition=fundamental","pubTime":"2025-02-27 16:05","pubTimestamp":1740643541,"startTime":"0","endTime":"0","summary":"Indian IT services major Wipro  said it is committing $200 million to its venture arm, Wipro Ventures, in its fourth funding round, according to a Wednesday release filed with the Indian bourses.The investment aims to accelerate backing for early- to mid-stage startups focused on technological innovation, Wipro said in the release.Wipro Ventures, launched in 2015, connects Wipro and its clients to a global ecosystem of startups, according to the release.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4543","LU0348723411.USD","IE00BMPRXR70.SGD","IE00BMPRXN33.USD","IE00BMPRXQ63.HKD","BK4585","BK4588","BK4141","BK4609"],"gpt_icon":1},{"id":"2514823030","title":"Shakti Pumps (India) Invests Additional INR60 Million in Wholly-Owned Arm; Shares Down 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514823030","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514823030?lang=en_us&edition=fundamental","pubTime":"2025-02-27 15:31","pubTimestamp":1740641519,"startTime":"0","endTime":"0","summary":"Shakti Pumps   has invested an additional 60 million Indian rupees in its wholly-owned subsidiary Shakti EV Mobility, according to a Thursday filing with the Indian stock exchanges.The company has subscribed to 6 million equity shares of face value of 10 rupees each to expand its operations.With this, the company's consolidated investment in Shakti EV Mobility has increased to 450 million rupees.Shakti EV Mobility is engaged in the business of manufacturing various types of electric vehicle motors and charger controllers.Shares of the company were down 5% in recent trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LU0348723411.USD","IE00BMPRXQ63.HKD","BK4585","EVMO","IE00BMPRXR70.SGD","BK4609","IE00BMPRXN33.USD","BK4141","BK4543"],"gpt_icon":1},{"id":"2514487088","title":"Jupiter Wagons Arm Bags Order Worth INR2.55 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2514487088","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514487088?lang=en_us&edition=fundamental","pubTime":"2025-02-27 12:07","pubTimestamp":1740629273,"startTime":"0","endTime":"0","summary":"Jupiter Tatravagonka Railwheel Factory, a subsidiary of Jupiter Wagons , has secured an order worth 2.55 billion Indian rupees from Braithwait & Co., according to a Thursday filing to the Indian stock exchanges.The contract is for the supply of 9,140 wheelsets of 840 mm diameter for 25-ton axle load applications.The deal increases the company's total order book to 5.60 billion rupees.The company aims to nearly double the contribution from its wheel business with a targeted revenue of 6 billion rupees business in the financial year 2025-26.The company expects revenue to be boosted by increased production capacity, strong order inflows, and enhanced domestic manufacturing capabilities, including setting up a new manufacturing facility in Odisha, India.Price : 305.90, Change: -1.9, Percent Change: -0.62%","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4543","INR.AU","INR","BK4609","IE00BMPRXN33.USD","BK4588","IE00BMPRXQ63.HKD","IE00BMPRXR70.SGD","BK7095","BK4141","BK4213","BK4585","LU0348723411.USD","BK7504"],"gpt_icon":1},{"id":"2514864158","title":"Why SOUN and GM Are Advancing Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2514864158","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514864158?lang=en_us&edition=fundamental","pubTime":"2025-02-27 03:37","pubTimestamp":1740598662,"startTime":"0","endTime":"0","summary":"SoundHound AI  and General Motors  are among the winners on Wall Street today, climbing 9% and 3.5%, respectively.SOUN yesterday announced that it had unveiled an updated AI platform for restaurants, while GM raised its dividend and unveiled a new share-buyback initiative.SoundHound AI yesterday reported that it had launched an updated version of its \"voice AI-powered platform for restaurants.\" The new system offers AI-powered, automated \"Call-to-Order, Text-to-Order, Scan-to-Order, and In-Car Voice Ordering,\" SOUN reported. Additionally, it is faster and more accurate than its predecessor.\"AI in restaurants is no longer optional – it’s the new standard. The future is omnichannel, and our advanced platform gives restaurants the flexibility to integrate automation across every customer touchpoint,\" SOUN Chief Product Officer James Horn said in a statement.Disclosure: None. This article is originally published at Insider Monkey.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-soun-gm-advancing-today-193742351.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4574","BK4516","LU1201861249.SGD","LU0130518102.USD","LU0006061336.USD","LU0477156797.USD","LU1201861165.SGD","BK4099","LU0162691827.USD","LU0345770993.USD","BK4559","LU0345770308.USD","BK4023","BK4555","LU0648001328.SGD","LU0980610538.SGD","BK4588","SOUN","LU0130103400.USD","LU0070302665.USD","BK4585","BK4608","LU0130517989.USD","LU0211331839.USD","BK4566","LU0208291251.USD","LU0130102774.USD","LU0072461881.USD","GM","BK4547","LU0477156953.USD","LU0320765489.SGD","LU0648000940.SGD","BK4561","BK4587","BK4596","BK4609"],"gpt_icon":1}],"pageSize":16,"totalPage":10,"pageCount":8,"totalSize":157}]}}